A patient diagnosed with STEMI is about to undergo a primary percutaneous coronary intervention (PCI). Which combination of pharmacotherapeutic agents will be given to augment this procedure?
A) Beta blocker and nitroglycerin
B) Abciximab and a fibrinolytic drug
C) Angiotensin-converting enzyme (ACE) inhibitor and aspirin
D) Heparin, aspirin, and clopidogrel

Question

Quizplus · Accepted Answer

Patients undergoing a primary PCI should receive heparin intravenously combined with aspirin and either clopidogrel or prasugrel. Abciximab and fibrinolytic drugs are not indicated. Beta blockers and nitroglycerin do not prevent thromboses. ACE inhibitors do not prevent thromboses.

A Patient Diagnosed with STEMI Is About to Undergo a Primary